SCHEMBL743418

SCHEMBL743418

COc1ccc(C(C)(C)NC(=O)c2cc3c(NC(=O)c4ccc(CN5CCC5)cc4)n[nH]c3s2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.60
BCR P11274 2/20 0.60
AURKA O14965 2/20 0.44
KDR P35968 1/20 0.44
CYP2C9 P11712 1/20 0.44
HIF1A Q16665 1/20 0.43
EPAS1 Q99814 1/20 0.43
PRKAB2 O43741 3/20 0.43
PRKAG1 P54619 3/20 0.43
PRKAA2 P54646 3/20 0.43
PRKAA1 Q13131 3/20 0.43
PRKAG3 Q9UGI9 3/20 0.43
PRKAG2 Q9UGJ0 3/20 0.43
PRKAB1 Q9Y478 3/20 0.43
KMT2A Q03164 2/20 0.43
HSD17B10 Q99714 1/20 0.43
PKM P14618 1/20 0.43
MCHR1 Q99705 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741481 0.98 ABL1 (0.62) ABL1BCRAURKAKDRCYP2C9
SCHEMBL741724 0.98 ABL1 (0.64) ABL1BCRAURKAKDRCYP2C9
SCHEMBL740986 0.93 ABL1 (0.54) ABL1BCRAURKAKDRHIF1A
SCHEMBL740798 0.93 ABL1 (0.59) ABL1BCRAURKAKDRCYP2C9
SCHEMBL740623 0.91 ABL1 (0.72) ABL1BCRAURKAKDRCYP2C9
SCHEMBL742323 0.91 ABL1 (0.61) ABL1BCRAURKAKDRCYP2C9
SCHEMBL742951 0.91 ABL1 (0.62) ABL1BCRAURKAKDRCYP2C9
SCHEMBL743126 0.90 ABL1 (0.62) ABL1BCRAURKAKDRCYP2C9
SCHEMBL742638 0.90 ABL1 (0.74) ABL1BCRAURKAKDRCYP2C9
SCHEMBL740752 0.89 ABL1 (0.76) ABL1BCRAURKAKDRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed